Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.40 |
| ▸ | THRA | P10827 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.39 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.39 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.37 |
| ▸ | BID | P55957 | 3/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.37 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.37 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5708963 | 0.99 | LIPG (0.41) | LIPGPPARAFUT7THRATHRB | |
| SCHEMBL27495854 | 0.89 | LIPG (0.45) | LIPGPPARATHRATHRBNR1H2 | |
| SCHEMBL7143805 | 0.88 | LIPG (0.41) | LIPGPPARAFUT7THRATHRB | |
| Ammonia Solution, Strong SCHEMBL27553670 | 0.88 | LIPG (0.44) | LIPGPPARATHRATHRBNR1H2 | |
| Sulfuric Acid SCHEMBL27540444 | 0.86 | LIPG (0.45) | LIPGPPARATHRATHRBNR1H2 | |
| Sulfuric Acid SCHEMBL27511026 | 0.85 | LIPG (0.50) | LIPGPPARATHRATHRBNR1H2 | |
| SCHEMBL2904403 | 0.85 | LIPG (0.55) | LIPGPPARATHRATHRBNR1H2 | |
| Bromide SCHEMBL5904514 | 0.83 | LIPG (0.53) | LIPGPPARATHRATHRBNR1H2 | |
| Hydrochloric Acid SCHEMBL5072856 | 0.83 | LIPG (0.53) | LIPGPPARATHRATHRBNR1H2 | |
| Hydrochloric Acid SCHEMBL2898929 | 0.83 | LIPG (0.53) | LIPGPPARATHRATHRBNR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160030476-A1 | Compositions, Methods And Devices For Promoting Wound Healing And Reducing Infection | IASIS MOLECULAR SCIENCES (US) | 2016-02-04 | — | — | US | claimed |
| WO-2014153238-A9 | COMPOSITIONS, METHODS AND DEVICES FOR PROMOTING WOUND HEALING AND REDUCING INFECTION | IASIS MOLECULAR SCIENCES (US) | 2014-12-04 | — | — | WO | claimed |
| US-20080199535-A1 | Compositions Having a High Antiviral and Antibacterial Efficacy | THE DIAL CORPORATION (US) | 2008-08-21 | — | — | US | claimed |
| US-20080138438-A1 | Compositions Having A High Antiviral And Antibacterial Efficacy | THE DIAL CPRPORATION (US) | 2008-06-12 | — | — | US | claimed |
| EP-1819229-A2 | COMPOSITIONS HAVING A HIGH ANTIVIRAL AND ANTIBACTERIAL EFFICACY | The Dial Corporation (US) | 2007-08-22 | — | — | EP | claimed |
| EP-1819222-A2 | COMPOSITIONS HAVING A HIGH ANTIVIRAL AND ANTIBACTERIAL EFFICACY | The Dial Corporation (US) | 2007-08-22 | — | — | EP | claimed |
| WO-2006062845-A2 | COMPOSITIONS HAVING A HIGH ANTIVIRAL AND ANTIBACTERIAL EFFICACY | THE DIAL CORPORATION (US) | 2006-06-15 | — | — | WO | claimed |
| WO-2006062846-A2 | COMPOSITIONS HAVING A HIGH ANTIVIRAL AND ANTIBACTERIAL EFFICACY | THE DIAL CORPORATION (US) | 2006-06-15 | — | — | WO | claimed |
| US-6616922-B2 | For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user | THE DIAL CORPORATION | 2003-09-09 | — | — | US | claimed |
| EP-0842248-B1 | BLOOMING TYPE, HARD SURFACE CLEANING AND/OR DISINFECTING COMPOSITIONS | RECKITT BENCKISER INC (US) | 2003-05-21 | — | — | EP | claimed |
| US-20030022941-A1 | For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user | Henkel IP & Holding GmbH (DE) | 2003-01-30 | — | — | US | claimed |
| WO-2002076207-A1 | ANTIBACTERIAL COMPOSITIONS | THE DIAL CORPORATION (US) | 2002-10-03 | — | — | WO | claimed |
| US-5591708-A | ALPHA-TERPINEOL, NONIONIC SURFACTANT AND SOLVENTS WITH WATER AND QUATERNARY AMMONIUM COMPOUND | RECKITT & COLMAN INC. (US) | 1997-01-07 | — | — | US | claimed |
| CN-118696113-A | Foaming acidic hard surface cleaning compositions | 联合利华知识产权控股有限公司 | 2024-09-24 | — | — | CN | disclosed |
| WO-2024133116-A1 | A FOAMABLE HARD SURFACE CLEANING COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2024-06-27 | — | — | WO | disclosed |
| EP-4244319-B1 | AQUEOUS ALKALINE ABRASIVE CLEANING COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2024-06-19 | — | — | EP | disclosed |
| US-5591708-A | ALPHA-TERPINEOL, NONIONIC SURFACTANT AND SOLVENTS WITH WATER AND QUATERNARY AMMONIUM COMPOUND | RECKITT & COLMAN INC. (US) | 1997-01-07 | — | — | US | disclosed |
| EP-0651048-A2 | Foaming antibacterial liquid formulation for cleaning kitchen surfaces | Reckitt & Colman Inc. (US) | 1995-05-03 | — | — | EP | disclosed |
| EP-0651049-A2 | Antimicrobial dish washing liquid | Reckitt & Colman Inc. (US) | 1995-05-03 | — | — | EP | disclosed |
| US-4902720-A | Treatment of virus infections with quaternary ammonium compounds | BALTECH, INC., A CORP. OF LA | 1990-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080138438-A1 | Compositions Having A High Antiviral And Antibacterial Efficacy | ZC3HAV1, ZC3HAV1L, ZFR | LIPG 1187/4885PPARA 425/4885FUT7 1153/4885 |
| US-20080199535-A1 | Compositions Having a High Antiviral and Antibacterial Efficacy | ZC3HAV1, ZC3HAV1L, ZFR | LIPG 1082/4885PPARA 1425/4885FUT7 707/4885 |
| US-20160030476-A1 | Compositions, Methods And Devices For Promoting Wound Healing And Reducing Infection | MMP8, IL1B, MMP1 | LIPG 410/4885PPARA 1007/4885FUT7 1615/4885 |
| US-20030022941-A1 | For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user | CUTA, CHIT1, CLSPN | LIPG 13/4885PPARA 2258/4885FUT7 152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.